AlphaMark Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-740
| Closed | – | – | 639 |
|
|
2019
Q4 | $0 | Sell |
740
-25
| -3% | – | ﹤0.01% | 529 |
|
|
2019
Q3 | $0 | Hold |
765
| – | – | ﹤0.01% | 534 |
|
|
2019
Q2 | $0 | Hold |
765
| – | – | ﹤0.01% | 543 |
|
|
2019
Q1 | $4K | Hold |
765
| – | – | ﹤0.01% | 432 |
|
|
2018
Q4 | $3K | Hold |
765
| – | – | ﹤0.01% | 428 |
|
|
2018
Q3 | $8K | Hold |
765
| – | – | ﹤0.01% | 376 |
|
|
2018
Q2 | $6K | Buy |
765
+25
| +3% | +$174 | ﹤0.01% | 429 |
|
|
2018
Q1 | $4K | Hold |
740
| – | – | ﹤0.01% | 444 |
|
|
2017
Q4 | $7K | Hold |
740
| – | – | ﹤0.01% | 390 |
|
|
2017
Q3 | $7K | Hold |
740
| – | – | ﹤0.01% | 379 |
|
|
2017
Q2 | $9K | Hold |
740
| – | – | ﹤0.01% | 362 |
|
|
2017
Q1 | $8K | Hold |
740
| – | – | ﹤0.01% | 359 |
|
|
2016
Q4 | $7K | Hold |
740
| – | – | ﹤0.01% | 354 |
|
|
2016
Q3 | $9K | Buy |
+740
| New | +$11.2K | ﹤0.01% | 254 |
|
AlphaMark Advisors's INSY Position: Q1 2020 in Review
AlphaMark Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q1 2020, closing a stake of 740 shares.
AlphaMark Advisors first reported a position in INSY in Q3 2016 and held it in 14 quarters. The position peaked at $9K in Q2 2017. 1 fund tracked by Wall St. Rank holds INSY as of Q1 2020.
- AlphaMark Advisors reported no remaining Insys Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
- AlphaMark Advisors sold 740 Insys Therapeutics, Inc. shares in Q1 2020.
- AlphaMark Advisors first reported a position in Insys Therapeutics, Inc. in Q3 2016 and held it in 14 quarters.
- AlphaMark Advisors's Insys Therapeutics, Inc. position peaked at $9K in Q2 2017.
- 1 fund tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2020.
Based on AlphaMark Advisors's 13F filing for Q1 2020, filed 24 Apr 2020.